GT Biopharma, Inc. (GTBP)
0.7852
-0.03
(-3.53%)
USD |
NASDAQ |
Dec 31, 16:00
0.7925
+0.01
(+0.93%)
After-Hours: 20:00
GT Biopharma Shareholders Equity (Quarterly): 3.00M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| SELLAS Life Sciences Group, Inc. | 45.63M |
| Lyell Immunopharma, Inc. | 329.12M |
| Plus Therapeutics, Inc. | 5.054M |
| Geron Corp. | 248.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.321M |
| Total Liabilities (Quarterly) | 1.321M |
| Current Ratio | 2.696 |